Leave or Remain: Britain votes on EU membership today

World leaders all the way from US President Barack Obama to Indian Prime Minister Narendra Modi, and not least the leaders of European countries, want Britain to remain in the European Union (EU). For more update visit www.marketmagnify.com/stock-cash-tips.php & Give a missed call @ 78-79-88-11-22.

           Brexit: Which Indian IT cos may gain or fall on EU referendum
 Bank of America Merrill Lynch feels that Brexit may create recession risks that could hurt IT demand further hurting 10-14 percent revenue growth for the UK businesses of the Indian IT companies in FY17.
              Brexit fears are totally overblown: Jim Cramer

Jim Cramer's jaw dropped to the floor by how overblown Brexit fears are when he read the op-ed by Matt Ridley in the Wall Street Journal entitled "The Business Case for Brexit.

             The Brexit conundrum: To be or not to be

 There's been a lot of talk around whether or not Britons will vote to stay in the European Union. Brexit, as it is called, will have repercussions on the UK, the EU as well as emerging markets like India. The referendum is set for June 23. Here is a look at how it would play out and what impact, if any, it would have on countries and currencies.
                Brexit will mean risk-off in EMs; India could be hurt too: LGM

The biggest casualty of a ‘leave’ vote would be the pound and the UK stock market which could fall as much as 5-10 percent feels Chowdhry

                 Lupin gets USFDA nod for fungal infection drug

Company's US subsidiary Gavis Pharmaceuticals LLC has received final approvals to market "its Voriconazole tablets, 50 mg & 200 mg and Voriconazole Oral Suspension, 40 mg/mL from the United States Food and Drug Administration (FDA)," Lupin said in a filing to BSE
                KEC International gains 7% on order win worth Rs 1036 crore

The company's transmission and distribution business has received an order worth Rs 666 crore in    

                    Drug to treat eye disease won't hit mkt before 2-3 yrs: Biocon

Early trials have indicated a positive data for the drug QPI-1007 to treat nonarteritic anterior ischemic optic neuropathy (NAION), says Kiran Mazumdar Shaw, CMD of Boicon.